Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
dulaglutide
Eli Lilly's Big Bet On Diabetes
Eli Lilly's Big Bet On Diabetes
Seeking Alpha
diabetes
dulaglutide
Eli Lily
empagliflozin
insulin
LY2605541
LY2963016
Clean Superiority Sweep For Dulaglutide Could Reshape Diabetes Market
Clean Superiority Sweep For Dulaglutide Could Reshape Diabetes Market
Seeking Alpha
diabetes
dulaglutide
Eli Lilly
Novo Nordisk
Sanofi
Lilly diabetes drug as good as insulin in study
Lilly diabetes drug as good as insulin in study
Reuters
diabetes
dulaglutide
Eli Lilly
insulin
3 Diabetes Phase 3 Wins
3 Diabetes Phase 3 Wins
Motley Fool
Amylin
AstraZeneca
Bristol-Myers Squibb
diabetes
dulaglutide
Eli Lilly
Merck
Sanofi
Lilly Diabetes Medicine Meets Goal in Three Studies
Lilly Diabetes Medicine Meets Goal in Three Studies
Bloomberg
diabetes
dulaglutide
Eli Lilly
Study highlights cardio safety of Lilly GLP-1 dulaglutide
Study highlights cardio safety of Lilly GLP-1 dulaglutide
Pharma Times, UK
diabetes
dulaglutide
Eli Lilly
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT